Analysis: Drug prices will soon be lowered massively. Big Pharma (Drug...

6y ago Jul 30, 2020 at 5:44 PM

Drug prices will soon be lowered massively. Big Pharma (Drug Companies) are advertising against me like crazy because lower prices mean less profit. When you watch a Fake Ad, just think lower drug prices!!!

0:00 0:00

AI Analysis

Machine-generated analysis of the post above on 2026-03-19. Not written by the author of the post.

Danger Level

None

Narcissistic State

Grandiose

Authorship

Uncertain

Intensity

42%

A routine grandiose-mode political messaging post functioning primarily as supply-seeking, with a mild narcissistic injury substrate. The post's most psychologically salient feature is characteristically narcissistic personalization: pharmaceutical companies advertising against a pricing policy become entities advertising "against me," collapsing the distinction between public office and personal identity. Defense mechanisms are standard for this subject — projection preemptively labels pharma advertising as "Fake Ads" without engaging content; rationalization reduces corporate opposition to pure greed; splitting enforces a binary hero-villain schema. Rhetorically, the post deploys practiced parasocial inoculation, recruiting followers as co-skeptics using Trump's established "Fake" lexicon before they encounter oppositional advertising. The closing behavioral imperative ("just think lower drug prices!!!") is unusually direct audience instruction. Authorship is assessed as likely authentic or closely dictated despite business-hours timing, given strong stylistic fingerprints. Cognitive status is unremarkable and consistent with baseline simplicity. Factual integrity is low: the centerpiece promise of "massively" lower prices was vague and historically unfulfilled, while the attribution of pharma advertising to personal animus is narcissistically inflated. No danger indicators. This post exemplifies the subject's operational template: convert policy conflict into personal combat narrative, preemptively delegitimize opposition, and position self as the people's lone champion against a powerful elite enemy.

Authorship Analysis

Uncertain

Indicators:

Parenthetical clarification '(Drug Companies)' — characteristic audience-education device
'Fake Ad' is a direct lexical derivative of established 'Fake News' brand
Personal victimhood framing 'against me like crazy' — narcissistic personalization of institutional opposition
Triple exclamation marks consistent with authentic posting style
Simple tripartite structure: promise → enemy motive → call to action

Psychological Profile

▶ State

Grandiose State

Trigger: Supply Seeking — Criticism (Pharmaceutical industry oppositional advertising campaigns against Trump drug pricing policies)

Sentiment

-0.20

▶ Clinical

Malignant Narcissism:

Narcissistic

62%

Antisocial

20%

Paranoid

38%

Sadism

Defense Mechanisms:

projectionrationalizationsplitting

Cognitive Complexity:

Complexity

28%

Parasocial Techniques:

Direct audience instruction: 'When you watch a Fake Ad, just think lower drug prices!!!' recruits followers as co-interpreters using Trump's epistemic frameShared enemy identification creates in-group cohesion against pharmaPreemptive inoculation: conditions audience to reject counter-information before encountering it

Danger Assessment

None

Gaslighting Detected:

'Fake Ad' label applied preemptively to all pharma advertising — attacks audiences' epistemic access to counter-information before they encounter it
Extends established 'Fake News' epistemic closure framework to a new domain (pharmaceutical advertising), conditioning rejection without evaluation

Reality Distortions:

Personalizing an institutional policy dispute as a personal campaign 'against me' — narcissistic conflation of office and identity
Vague future promise ('will soon be lowered massively') presented with false certainty despite absence of operative mechanism

Fact Checks (3)

"Drug prices will soon be lowered massively"

Mostly False

Trump had issued executive orders on drug pricing in this period (international reference pricing, most-favored-nation pricing) and the $65M Kodak pharmaceutical loan was just announced. However, no mechanism existed to produce 'massive' reductions; independent analyses showed drug prices continued rising through 2020-2021. The promise is vague, self-serving, and historically unfulfilled.

"Big Pharma are advertising against me like crazy"

Mostly True

Pharmaceutical companies did fund advertising campaigns opposing Trump's drug pricing policies, particularly the international reference pricing executive orders. The factual basis is real; the 'against me' personalization is narcissistically inflected but the underlying phenomenon of pharma opposition advertising is documented.

"Lower prices mean less profit [for drug companies]"

True

As a general economic principle applied to pharmaceutical companies whose drug pricing substantially exceeds marginal cost, lower prices would reduce profit margins. Broadly accurate, though pharmaceutical economics involve R&D cost recovery and tiered pricing complexity that the simplified framing omits.

Receipts

No contradictions with other posts detected yet.

Psychological & Rhetorical Analysis — July 30, 2020

Authorship Attribution

The 17:44 UTC timestamp converts to 1:44 PM EDT (Trump was in Washington D.C. as sitting president, observing EDT, UTC−4). Business hours are a mild aide-authorship indicator. However, the stylistic fingerprint tilts toward authentic Trump: the parenthetical clarification ("Drug Companies") that condescends-to-educate his base; the personally victimized framing ("against me like crazy"); the "Fake Ad" construction, a direct lexical relative of his "Fake News" brand; the triple exclamation marks; and the simple tripartite thought structure (promise → explanation of enemy's motive → call to action). The post reads as dictated or composed impulsively, possibly reviewed lightly. Confidence: medium for authentic-leaning authorship.

Psychological State & Triggers

The post is grandiose-mode with a supply-seeking trigger layered over a mild narcissistic injury. Pharmaceutical companies running oppositional advertising constitutes an institutional challenge to a policy Trump associated with his personal brand. His response is characteristically personalizing: a corporate opposition campaign becomes "advertising against me like crazy." This conflation of self with policy—and policy with self-worth—is a defining narcissistic feature. The grandiosity is not at its peak here; the post is buoyant rather than enraged, reflecting confidence rather than persecution.

Trigger type: Supply-seeking + narcissistic injury (criticism of a Trump-branded initiative by powerful institutional actors)

Narcissistic Dynamics

State: Grandiose — expansive promise ("will soon be lowered massively"), confident combat framing, no victimhood retreat
Rage: Absent. Irritation present ("like crazy") but modulated and redirected into populist framing
Target: Big Pharma as proxy for elites conspiring against both Trump and the people

The paranoid undertone (pharma coordinating against him personally) is characteristic but not elevated for this subject. It functions more as a rhetorical device than a genuine delusional frame.

Defense Mechanisms

Projection (immature): Calling pharma's ads "Fake Ads" preemptively discredits their messaging while deflecting scrutiny from the vagueness of his own pricing promises
Rationalization (neurotic): Reducing pharma's entire policy position to simple greed ("lower prices mean less profit") forecloses any legitimate substantive objection
Splitting (immature): Binary framing — Trump = champion of the people; pharma = corrupt profiteers. No intermediate complexity

Multi-Level Personality Framework

Level 1 — Dispositional Traits (salient in this post):

Extraversion high: assertive, energetic, combat-positive
Agreeableness very low: adversarial, combative, zero concession to opposition's legitimacy
Neuroticism moderate: personalizing an institutional campaign as directed at him
Conscientiousness low-moderate: vague promises with no mechanism stated
Openness low: closed, moralistic, populist frame

Level 2 — Characteristic Adaptations:

Agency motive dominant: Power and status through combat framing; positioning as the decisive actor who will "massively" lower prices
Schema: World is populated by self-interested enemies who must be exposed; the leader's role is to name and neutralize them on behalf of the people

Level 3 — Narrative Identity:

Protagonist role: Warrior/Champion — fighting entrenched corporate power
Narrative sequence: Contamination-to-redemption implied — pharma's corrupt opposition is itself evidence that Trump's crusade is righteous
Identity claim: "I am the one taking on powerful interests for ordinary Americans"
Contrasting other: Big Pharma as corrupt elite (classic populist shadow projection)

Rhetorical Techniques

Populist hero-villain framing: Explicit corporate villain, implicit working-class beneficiary
Hyperbole: "massively," "like crazy"
Preemptive credibility attack: Labeling all pharma ads "Fake Ads" before audiences have evaluated them — inoculation technique
Appeal to self-interest: Voter's pocketbook (drug costs) linked directly to Trump's success against pharma
Parasocial instruction: "When you watch a Fake Ad, just think lower drug prices!!!" — recruits the audience as co-interpreters using Trump's frame; builds parasocial bond through shared skepticism
Parenthetical education of base: "(Drug Companies)" — condescending simplification that simultaneously signals awareness of audience and reinforces insider/outsider dynamic

Propaganda technique: RAND Firehose element — preemptive reality framing that delegitimizes counter-information before it lands.

Dehumanizing language: Absent. Violent imagery: Absent. Stochastic terrorism: Absent.

Fact Verification

Claim	Verdict	Evidence
"Drug prices will soon be lowered massively"	Mostly False	Trump had issued executive orders on drug pricing in this period (international reference pricing, most-favored-nation pricing) and the $65M Kodak pharmaceutical loan was just announced. However, no mechanism existed to produce 'massive' reductions; independent analyses showed drug prices continued rising through 2020-2021. The promise is vague, self-serving, and historically unfulfilled.
"Big Pharma are advertising against me like crazy"	Mostly True	Pharmaceutical companies did fund advertising campaigns opposing Trump's drug pricing policies, particularly the international reference pricing executive orders. The factual basis is real; the 'against me' personalization is narcissistically inflected but the underlying phenomenon of pharma opposition advertising is documented.
"Lower prices mean less profit [for drug companies]"	True	As a general economic principle applied to pharmaceutical companies whose drug pricing substantially exceeds marginal cost, lower prices would reduce profit margins. Broadly accurate, though pharmaceutical economics involve R&D cost recovery and tiered pricing complexity that the simplified framing omits.

Overall Veracity: 67%